The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antihistamine Drugs Market Research Report 2024
Synopsis
Antihistamines are a class of drugs that inhibit the action of histamine by attacking the specific cell receptors meant for histamines. Histamine is an immune substance released by body’s immune system upon attack by allergens or due to intake of histamine-deficient food, some food items also trigger their excessive production which creates immune response.
The global Antihistamine Drugs market was valued at US$ 194.5 million in 2023 and is anticipated to reach US$ 292.8 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antihistamine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antihistamine Drugs.
Report Scope
The Antihistamine Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antihistamine Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antihistamine Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
Bayer
Almirall
Meda Consumer Healthcare
AstraZeneca
Johnson & Johnson
Novartis
Sanofi
Pfizer
Boehringer Ingelheim
Akorn
Merck & Co.
Teva Pharmaceutical
Segment by Type
Prescription-based Antihistamine Drugs
Over-the-counter(OTC) Antihistamine Drugs
Segment by Sale Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antihistamine Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antihistamine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Antihistamines are a class of drugs that inhibit the action of histamine by attacking the specific cell receptors meant for histamines. Histamine is an immune substance released by body’s immune system upon attack by allergens or due to intake of histamine-deficient food, some food items also trigger their excessive production which creates immune response.
The global Antihistamine Drugs market was valued at US$ 194.5 million in 2023 and is anticipated to reach US$ 292.8 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antihistamine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antihistamine Drugs.
Report Scope
The Antihistamine Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antihistamine Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antihistamine Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
Bayer
Almirall
Meda Consumer Healthcare
AstraZeneca
Johnson & Johnson
Novartis
Sanofi
Pfizer
Boehringer Ingelheim
Akorn
Merck & Co.
Teva Pharmaceutical
Segment by Type
Prescription-based Antihistamine Drugs
Over-the-counter(OTC) Antihistamine Drugs
Segment by Sale Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antihistamine Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antihistamine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antihistamine Drugs Market Overview
1.1 Product Overview and Scope of Antihistamine Drugs
1.2 Antihistamine Drugs Segment by Type
1.2.1 Global Antihistamine Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Prescription-based Antihistamine Drugs
1.2.3 Over-the-counter(OTC) Antihistamine Drugs
1.3 Antihistamine Drugs Segment by Sale Channel
1.3.1 Global Antihistamine Drugs Market Value by Sale Channel: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Antihistamine Drugs Market Size Estimates and Forecasts
1.4.1 Global Antihistamine Drugs Revenue 2019-2030
1.4.2 Global Antihistamine Drugs Sales 2019-2030
1.4.3 Global Antihistamine Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antihistamine Drugs Market Competition by Manufacturers
2.1 Global Antihistamine Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antihistamine Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antihistamine Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Antihistamine Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antihistamine Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antihistamine Drugs, Product Type & Application
2.7 Antihistamine Drugs Market Competitive Situation and Trends
2.7.1 Antihistamine Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antihistamine Drugs Players Market Share by Revenue
2.7.3 Global Antihistamine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antihistamine Drugs Retrospective Market Scenario by Region
3.1 Global Antihistamine Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antihistamine Drugs Global Antihistamine Drugs Sales by Region: 2019-2030
3.2.1 Global Antihistamine Drugs Sales by Region: 2019-2024
3.2.2 Global Antihistamine Drugs Sales by Region: 2025-2030
3.3 Global Antihistamine Drugs Global Antihistamine Drugs Revenue by Region: 2019-2030
3.3.1 Global Antihistamine Drugs Revenue by Region: 2019-2024
3.3.2 Global Antihistamine Drugs Revenue by Region: 2025-2030
3.4 North America Antihistamine Drugs Market Facts & Figures by Country
3.4.1 North America Antihistamine Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antihistamine Drugs Sales by Country (2019-2030)
3.4.3 North America Antihistamine Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antihistamine Drugs Market Facts & Figures by Country
3.5.1 Europe Antihistamine Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antihistamine Drugs Sales by Country (2019-2030)
3.5.3 Europe Antihistamine Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antihistamine Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Antihistamine Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antihistamine Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Antihistamine Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antihistamine Drugs Market Facts & Figures by Country
3.7.1 Latin America Antihistamine Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antihistamine Drugs Sales by Country (2019-2030)
3.7.3 Latin America Antihistamine Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antihistamine Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Antihistamine Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antihistamine Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antihistamine Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antihistamine Drugs Sales by Type (2019-2030)
4.1.1 Global Antihistamine Drugs Sales by Type (2019-2024)
4.1.2 Global Antihistamine Drugs Sales by Type (2025-2030)
4.1.3 Global Antihistamine Drugs Sales Market Share by Type (2019-2030)
4.2 Global Antihistamine Drugs Revenue by Type (2019-2030)
4.2.1 Global Antihistamine Drugs Revenue by Type (2019-2024)
4.2.2 Global Antihistamine Drugs Revenue by Type (2025-2030)
4.2.3 Global Antihistamine Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Antihistamine Drugs Price by Type (2019-2030)
5 Segment by Sale Channel
5.1 Global Antihistamine Drugs Sales by Sale Channel (2019-2030)
5.1.1 Global Antihistamine Drugs Sales by Sale Channel (2019-2024)
5.1.2 Global Antihistamine Drugs Sales by Sale Channel (2025-2030)
5.1.3 Global Antihistamine Drugs Sales Market Share by Sale Channel (2019-2030)
5.2 Global Antihistamine Drugs Revenue by Sale Channel (2019-2030)
5.2.1 Global Antihistamine Drugs Revenue by Sale Channel (2019-2024)
5.2.2 Global Antihistamine Drugs Revenue by Sale Channel (2025-2030)
5.2.3 Global Antihistamine Drugs Revenue Market Share by Sale Channel (2019-2030)
5.3 Global Antihistamine Drugs Price by Sale Channel (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Antihistamine Drugs Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Almirall
6.2.1 Almirall Corporation Information
6.2.2 Almirall Description and Business Overview
6.2.3 Almirall Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Almirall Antihistamine Drugs Product Portfolio
6.2.5 Almirall Recent Developments/Updates
6.3 Meda Consumer Healthcare
6.3.1 Meda Consumer Healthcare Corporation Information
6.3.2 Meda Consumer Healthcare Description and Business Overview
6.3.3 Meda Consumer Healthcare Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Meda Consumer Healthcare Antihistamine Drugs Product Portfolio
6.3.5 Meda Consumer Healthcare Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Antihistamine Drugs Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Antihistamine Drugs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Antihistamine Drugs Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Antihistamine Drugs Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Antihistamine Drugs Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Boehringer Ingelheim Antihistamine Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Akorn Antihistamine Drugs Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 Merck & Co.
6.11.1 Merck & Co. Corporation Information
6.11.2 Merck & Co. Antihistamine Drugs Description and Business Overview
6.11.3 Merck & Co. Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Merck & Co. Antihistamine Drugs Product Portfolio
6.11.5 Merck & Co. Recent Developments/Updates
6.12 Teva Pharmaceutical
6.12.1 Teva Pharmaceutical Corporation Information
6.12.2 Teva Pharmaceutical Antihistamine Drugs Description and Business Overview
6.12.3 Teva Pharmaceutical Antihistamine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Teva Pharmaceutical Antihistamine Drugs Product Portfolio
6.12.5 Teva Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antihistamine Drugs Industry Chain Analysis
7.2 Antihistamine Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antihistamine Drugs Production Mode & Process
7.4 Antihistamine Drugs Sales and Marketing
7.4.1 Antihistamine Drugs Sales Channels
7.4.2 Antihistamine Drugs Distributors
7.5 Antihistamine Drugs Customers
8 Antihistamine Drugs Market Dynamics
8.1 Antihistamine Drugs Industry Trends
8.2 Antihistamine Drugs Market Drivers
8.3 Antihistamine Drugs Market Challenges
8.4 Antihistamine Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
